Rna modulating oligonucleotides with improved characteristics for treating neuromuscular disorders
WO2020089325A1
Bispecific antisense oligonucleotides for dystrophin exon skipping
JP2019134706A
Rna modulating oligonucleotides with improved characteristics for treatment of duchenne and becker muscular dystrophy
JP2019030330A
Oligonucleotide for the treatment of muscular dystrophy patients
USRE48468E
Means and methods for counteracting muscle disorders
KR20190104021A
Substances for Targeting Various Selected Organs or Tissues
MX2018016253A
Pre-mrna splice switching or modulating oligonucleotides comprising bicyclic scaffold moieties, with improved characteristics for the treatment of genetic disorders.
BR112014026285A2
RNA-modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
EP2516647A1
Molecule for treating an inflammatory disorder
EP2344637A1
Methods and means for efficient skipping of exon 45 in duchenne muscular dystrophy pre-mrna
EP2505211A1
Molecules for targeting compounds to various selected organs or tissues
